Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer

NCT00258232 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: capecitabine
DRUG: celecoxib
DRUG: irinotecan hydrochloride

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

[object Object]